Literature DB >> 6820372

Sensitivity of luteinizing hormone and gonadal steroid responses to single intranasal administration of an LHRH agonist (Hoe-766) in young normal adult men.

N Faure, F Labrie, A Belanger, A Lemay, J P Raynaud, M Von der Ohe, A T Fazekas.   

Abstract

Entities:  

Keywords:  Age Factors; Androgens; Biology; Endocrine System; Estradiol--analysis; Estrogens; Follicle Stimulating Hormone--analysis; Gonadotropins; Gonadotropins, Pituitary; Hormones; Luteinizing Hormone--analysis; Men; Physiology; Pituitary Hormone Releasing Hormones--administraction and dosage; Progestational Hormones; Progesterone--analysis; Stanolone--analysis; Testosterone--analysis

Mesh：

Substances：

Year:  1982        PMID： 6820372     DOI： 10.1007/BF03350532

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN： 0391-4097            Impact factor:   4.256


× No keyword cloud information.
  18 in total

1.  Normal adults and subjects with hypogonadotropic hypogonadism respond differently to D-Ser(TBU)6-LH-RH-EA10.

Authors:  R Smith; R A Donald; E A Espiner; S G Stronach; I A Edwards
Journal:  J Clin Endocrinol Metab       Date:  1979-01       Impact factor: 5.958

2.  Luteinizing hormone-releasing hormone-induced regulation of gonadotropin and prolactin receptors in the rat testis.

Authors:  K J Catt; A J Baukal; T F Davies; M L Dufau
Journal:  Endocrinology       Date:  1979-01       Impact factor: 4.736

3.  Inhibition of testicular luteinizing hormone receptor level by treatment with a potent luteinizing hormone-releasing hormone agonist of human chorionic gonadotropin.

Authors:  C Auclair; P A Kelly; F Labrie; D H Coy; A V Schally
Journal:  Biochem Biophys Res Commun       Date:  1977-06-06       Impact factor: 3.575

4.  Extra-pituitary inhibition of testicular function by luteinising hormone releasing hormone.

Authors:  A J Hsueh; G F Erickson
Journal:  Nature       Date:  1979-09-06       Impact factor: 49.962

5.  Inhibitory effects of a single intranasal administration of [D-Ser(TBU)6, des-Gly-NH210]LHRH ethylamide, a potent LHRH agonist, on serum steroid levels in normal adult men.

Authors:  A Bélanger; F Labrie; A Lemay; S Caron; J P Raynaud
Journal:  J Steroid Biochem       Date:  1980-02       Impact factor: 4.292

6.  Inhibitory effects of long term treatment with a luteinizing hormone-releasing hormone agonist on the pituitary-gonadal axis in male and female rats.

Authors:  L Cusan; C Auclair; A Belanger; L Ferland; P A Kelly; C Seguin; F Labrie
Journal:  Endocrinology       Date:  1979-05       Impact factor: 4.736

7.  Down-regulation of testicular androgen biosynthesis and LH receptor levels by an LHRH agonist: role of prolactin.

Authors:  A Belanger; C Auclair; C Seguin; P A Kelly; F Labrie
Journal:  Mol Cell Endocrinol       Date:  1979-01       Impact factor: 4.102

8.  Pituitary gonadotropin inhibition by a highly active analog of luteinizing hormone-releasing hormone.

Authors:  J Sandow; W Von Rechenberg; G Jerzabek; W Stoll
Journal:  Fertil Steril       Date:  1978-08       Impact factor: 7.329

9.  Inhibition of spermatogenesis in the rat by treatment with [D-Ala6, Des-Gly-NH210] LHRH ethylamide.

Authors:  G Pelletier; L Cusan; C Auclair; P A Kelly; L Désy; F Labrie
Journal:  Endocrinology       Date:  1978-08       Impact factor: 4.736

10.  Testicular GnRH receptors--characterization and localization on interstitial tissue.

Authors:  G A Bourne; S Regiani; A H Payne; J C Marshall
Journal:  J Clin Endocrinol Metab       Date:  1980-08       Impact factor: 5.958
View more
  1 in total

Review 1.  Buserelin. A review of its pharmacodynamic and pharmacokinetic properties, and clinical profile.

Authors:  R N Brogden; M M Buckley; A Ward
Journal:  Drugs       Date:  1990-03       Impact factor: 9.546
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.